Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.
about
Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal CancerNew Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal CancerLumican effects in the control of tumour progression and their links with metalloproteinases and integrinsGene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.Current debate in the oncologic management of rectal cancer.DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.Genomic and oncoproteomic advances in detection and treatment of colorectal cancerHigh Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer.Functional Genomics and a New Era in Radiation Biology and Oncology.Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsRecent advances in the management of carcinoma of the rectumPrediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsetsYKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyIdentification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancerGenomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patientsAn integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerHigh-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyPredicting response to clinical radiotherapy: past, present, and future directions.Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers.Adjuvant therapy for rectal cancerRadio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Using gene expression profiling to predict response and prognosis in gastrointestinal cancers-the promise and the perils.Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer.Radiotherapy response in microsatellite instability related rectal cancerGene expression profile is associated with chemoradiation resistance in rectal cancer.Predictive markers of radiotherapy-induced rectal cancer regression.Endoscopic biopsies from gastrointestinal carcinomas and their suitability for molecular analysis: a review of the literature and recommendations for clinical practice and research.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.
P2860
Q26778557-B92B5E7F-419A-45E1-B3AD-05419D6DAA63Q26786311-B5AC47D4-F805-4C44-8D1B-622CB202A8CBQ26823441-9E3458A5-B762-4481-AB30-FC3CBB4ACE68Q27852191-B8D85086-C8FF-49AB-8CF9-275987BE867FQ27853327-618676C6-FFD1-4BDE-B0B6-5525CFE64E2DQ28072948-7C5DC01A-F0B3-44E1-83EC-B14251B4164CQ32874862-4D184DCC-B151-4371-B79E-422C23DE692EQ33425477-31C09591-AB07-44B4-94E6-A92FBC1A0616Q33702374-E029BCA1-6491-4731-B25C-0D7EF5372998Q34218803-53261C69-63F4-4979-87F6-A3D6B0D4999AQ34356765-9DC90B81-1C19-4F6A-900A-110226736C43Q34473018-4065500F-55A8-439D-9195-660C36D60CEAQ34572724-32D5AD26-623F-431C-B866-A9105B7193AAQ34787505-33854418-C549-411A-B820-269105FB13B0Q35026254-BF41FC2E-EDAE-47FE-A666-C8BDA7AB3844Q35083126-27501D73-8638-4A86-9C16-08345FD2FA8FQ35433475-2FE2679C-F63C-4F7D-A2D9-C5D70FEC2EB2Q35460703-7A4665F6-4AE3-465B-BBEF-20E1E1336B9AQ35607847-4A5E7309-2708-40B1-9D4A-9C7F8AA9B65CQ35859128-88A4270B-BC49-415B-8161-15C35D59BDD9Q36211293-D29AEFFB-3E7E-4077-A637-880908F2BF45Q36544900-399E42C1-64C8-4E96-AB61-0B59CC0106D1Q36677697-438214AB-E5EE-45E7-9565-AEA2F15A9895Q36720707-7CF9B968-3FE6-4349-80FE-5DC8314BCF3EQ37106318-2566E376-4152-4CAE-9FA2-121D535C2B0CQ37123131-BB217AFE-A929-4E8B-AF44-3F7A31B7B80AQ37298667-535F7FF5-E286-435C-BE0D-9898BC8050F7Q37414202-C9D2BF15-7829-4545-841D-BC08505B9A40Q37462241-C6016990-DECC-4F37-9565-64294611C509Q37629544-CC4E4D18-2BA0-4773-A4AB-ABF3D7C743DAQ37709253-BC71D3B2-C6CF-4BA9-8A30-A8204747BAA0Q37729169-6FC2BDE3-5F44-4DEF-864C-ADFE2AEF04DEQ37812009-E9BA4944-EDEA-4E81-ABEB-C18B9B001F64Q38019396-3E83EA46-ABC2-49A3-8DCA-4926B086A98AQ38021958-91AC7EAA-E705-4CBB-A526-F91DC5E5D964Q38088639-481633A3-00E7-41D3-87AB-81A6405F4E3EQ38137324-480122BB-6A99-44B3-9062-79D6A18AED15Q38239477-A144EDC0-58B4-4AA5-A519-CD0381C9EDD5Q38272251-B8724FC4-9F95-4088-9604-4C518869382EQ38594617-ADD874A3-6699-40E2-A26B-7D962FB971ED
P2860
Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prediction of sensitivity of r ...... s of gene expression profiles.
@en
Prediction of sensitivity of r ...... s of gene expression profiles.
@nl
type
label
Prediction of sensitivity of r ...... s of gene expression profiles.
@en
Prediction of sensitivity of r ...... s of gene expression profiles.
@nl
prefLabel
Prediction of sensitivity of r ...... s of gene expression profiles.
@en
Prediction of sensitivity of r ...... s of gene expression profiles.
@nl
P2093
P1433
P1476
Prediction of sensitivity of r ...... s of gene expression profiles.
@en
P2093
Hirokazu Nagawa
Junichiro Tanaka
Masatoshi Shirane
Takamitsu Kanazawa
Tetsuichiro Muto
Tomomichi Kiyomatsu
Toshiaki Tanaka
Toshiaki Watanabe
Yasuhiro Komuro
Yoko Yamamoto
P304
P356
10.1158/0008-5472.CAN-05-3834
P407
P577
2006-04-01T00:00:00Z